LIVZON PHARMA (01513) has accumulated repurchased 9.426 million shares of A shares.
Lizhu Pharmaceutical (01513) announced that as of February 28, 2025, the company has completed the centralized auction trading...
LIVZON PHARMA (01513) announced that as of February 28, 2025, the company repurchased a total of 9.426 million A shares through centralized bidding trading, accounting for 1.03% of the total share capital. The highest purchase price was RMB 38.37 per share, the lowest price was RMB 35.18 per share, and the total amount of funds used was RMB 342 million (excluding transaction costs). The repurchase mentioned above complies with the company's established share repurchase program.
Related Articles
New Stock Analysis | Wangshan Wangshui: From 6.42 million profit to 2.18 billion loss, the cash flow cliff and the hundred billion market gamble behind nine pipelines.
Guosheng Securities: It is almost certain that the Federal Reserve will continue to cut interest rates in October and December. It is expected that there will be three more rate cuts in 2026.
CMSC: Hong Kong stocks return to growth style after adjustment, focusing on internet and insurance.
New Stock Analysis | Wangshan Wangshui: From 6.42 million profit to 2.18 billion loss, the cash flow cliff and the hundred billion market gamble behind nine pipelines.
Guosheng Securities: It is almost certain that the Federal Reserve will continue to cut interest rates in October and December. It is expected that there will be three more rate cuts in 2026.
CMSC: Hong Kong stocks return to growth style after adjustment, focusing on internet and insurance.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
